| Vibrio alginolyticus | |
|---|---|
Scientific classification 
| |
| Domain: | Bacteria |
| Phylum: | Pseudomonadota |
| Class: | Gammaproteobacteria |
| Order: | Vibrionales |
| Family: | Vibrionaceae |
| Genus: | Vibrio |
| Species: | V. alginolyticus
|
| Binomial name | |
| Vibrio alginolyticus (Miyamoto et al. 1961)
Sakazaki 1968 | |
| Type strain | |
| ATCC 17749 CAIM 516 CCUG 4989 and 13445 and 16315 CIP 103336 and 75.3 DSM 2171 LMG 4409 NBRC 15630 NCCB 71013 and 77003 NCTC 12160 | |
| Synonyms | |
|
Oceanomonas alginolytica Miyamoto et al. 1961 | |
Vibrio alginolyticus is a Gram-negative marine bacterium.[1][2] It is medically important since it causes otitis and wound infection.[1] It is also present in the bodies of animals such as pufferfish, where it is responsible for the production of the potent neurotoxin, tetrodotoxin.[3]
Vibrio alginolyticus are commonly found in aquatic environments. Some strains of V. alginolyticus are highly salt tolerant and commonly found in marine environment. S.I. Paul et al. (2021)[2] isolated and identified many strains of Vibrio alginolyticus from nine marine sponges of the Saint Martin's Island Area of the Bay of Bengal, Bangladesh.
V. alginolyticus was first identified as a pathogen of humans in 1973. It occasionally causes eye, ear, and wound infections. It is a highly salt-tolerant species and can grow in salt concentrations of 10%. Most clinical isolates come from superinfected wounds that become contaminated at the beach. Tetracycline is typically an effective treatment. V. alginolyticus is rare cause of bacteremia in immunocompromised hosts.[4]